Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis

NCT04159610 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study was not pursued for internal reasons

Conditions

Primary Axillary Hyperhidrosis

Interventions

DRUG: WO3970
DRUG: Qbrexza® (glycopyrronium) cloth, 2.4%, for topical use

Sponsor

Dr. August Wolff GmbH & Co. KG Arzneimittel

Collaborators

[object Object]